Schrödinger (NASDAQ:SDGR – Get Free Report) posted its quarterly earnings data on Tuesday. The company reported ($0.52) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.40) by ($0.12), Zacks reports. The business had revenue of $35.30 million during the quarter, compared to the consensus estimate of $41.25 million. Schrödinger had a negative net margin of 91.84% and a negative return on equity of 35.77%. The business’s revenue for the quarter was down 17.1% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.86) EPS. Schrödinger updated its FY 2024 guidance to EPS.
Schrödinger Price Performance
SDGR stock traded up $0.57 during trading on Wednesday, reaching $22.82. 676,855 shares of the company were exchanged, compared to its average volume of 752,137. The company has a 50-day moving average of $18.73 and a two-hundred day moving average of $20.41. Schrödinger has a twelve month low of $16.67 and a twelve month high of $38.00.
Insider Buying and Selling
In related news, insider Margaret Dugan sold 1,531 shares of the company’s stock in a transaction that occurred on Tuesday, October 15th. The shares were sold at an average price of $17.78, for a total transaction of $27,221.18. Following the completion of the transaction, the insider now directly owns 13,469 shares in the company, valued at $239,478.82. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 8.60% of the stock is owned by corporate insiders.
Analysts Set New Price Targets
Check Out Our Latest Stock Report on Schrödinger
Schrödinger Company Profile
Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.
Recommended Stories
- Five stocks we like better than Schrödinger
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Rocket Lab is the Right Stock for the Right Time
- What is Forex and How Does it Work?
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- Find and Profitably Trade Stocks at 52-Week Lows
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for Schrödinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrödinger and related companies with MarketBeat.com's FREE daily email newsletter.